Merck gets Japanese nod for TEPMETKO(tepotinib) for non-small cell lung cancer Medical Dialogues Bureau28 March 2020 6:15 AM GMTTEPMETKO is the first regulatory approval globally for an oral MET inhibitor indicated for the treatment of advanced NSCLC harboring MET gene...
